Dynamics of urinary KIM-1 as a biomarker of acute kidney injury in cancer patients undergoing cisplatin-based chemotherapy | Sergeeva | Siberian journal of oncology

Siberian journal of oncology
Sibirskij onkologičeskij žurnal

ISSN 1814-4861 (Print)
ISSN 2312-3168 (Online)

eng | рус

Preview

Siberian journal of oncology

Advanced search

Archives

Download this PDF file

For citations:

Sergeeva N.S., Karmakova T.A., Savchina V.V., Deshkina T.I., Karpenko E.Yu., Bolotina L.V., Alentov I.I., Marshutina N.V., Fedenko A.A. Dynamics of urinary KIM-1 as a biomarker of acute kidney injury in cancer patients undergoing cisplatin-based chemotherapy. Siberian journal of oncology. 2023;22(4):44-54. (In Russ.) https://doi.org/10.21294/1814-4861-2023-22-4-44-54

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1814-4861 (Print)
ISSN 2312-3168 (Online)

Editor-in-Chief

Evgeny L. Choynzonov

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Notifications

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

N. S. Sergeeva
P.A. Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russia
Russian Federation

Natalia S. Sergeeva, Professor, Head of the Department of Predicting the Effectiveness of Conservative Therapy,
Researcher ID (WOS): I-2033-2014. Author ID (Scopus): 7102748586

3, 2nd Botkinsky proezd, 125284, Moscow

T. A. Karmakova
P.A. Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russia
Russian Federation

Tatiana A. Karmakova, DSc, Leading Researcher of the Department of Predicting the Effectiveness of Conservative Therapy,
Researcher ID (WOS): L-3592-2018. Author ID (Scopus): 6603382243

3, 2nd Botkinsky proezd, 125284, Moscow

V. V. Savchina
P.A. Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russia
Russian Federation

Victoria V. Savchina, MD, Researcher of the Department of Anticancer Drug Therapy,

3, 2nd Botkinsky proezd, 125284, Moscow

T. I. Deshkina
P.A. Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russia
Russian Federation

Tatiana I. Deshkina, MD, PhD, Senior Researcher of the Chemotherapy Department,
Researcher ID (WOS): ABA-8269-2022. Author ID (Scopus): 57218694102

3, 2nd Botkinsky proezd, 125284, Moscow

E. Yu. Karpenko
P.A. Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russia
Russian Federation

Elena Yu. Karpenko, MD, Junior Researcher of the Chemotherapy Department,
Author ID (Scopus): 57215966473.

3, 2nd Botkinsky proezd, 125284, Moscow

L. V. Bolotina
P.A. Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russia
Russian Federation

Larisa V. Bolotina, MD, DSc, Head of the Chemotherapy Department,
Researcher ID (WOS): U-5441-2019. Author ID (Scopus): 6603382243.

3, 2nd Botkinsky proezd, 125284, Moscow

I. I. Alentov
P.A. Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russia
Russian Federation

Igor I. Alentov, PhD, Senior Researcher of the Department of Predicting the Effectiveness of Conservative Therapy,
Author ID (Scopus): 54683346300.

3, 2nd Botkinsky proezd, 125284, Moscow

N. V. Marshutina
P.A. Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russia
Russian Federation

Nina V. Marshutina, PhD, Researcher of the Department of Predicting the Effectiveness of Conservative Therapy,
Researcher ID (WOS): I-2027-2014. Author ID (Scopus): 6602904590.

3, 2nd Botkinsky proezd, 125284, Moscow

A. A. Fedenko
P.A. Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russia
Russian Federation

Alexander A. Fedenko, MD, DSc, Head of the Department of Anticancer Drug Therapy,
Author ID (Scopus): 35344725600.

3, 2nd Botkinsky proezd, 125284, Moscow